Notify me when M.D. Ph.D. Hoyoung Huh files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | Ordinary shares, $0.000000005 par value | 18% | $4,367,927,440 | +$2,377,245,520 | 18,199,697,667 | +119% | Hoyoung Huh, M.D., Ph.D. | 02 Mar 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|